Screener
Surgery Partners, Inc. SGRY Q3 2026 earnings
Reported November 9, 2026 · After market close
Revenue$815.3MMiss by $5.7M
EPS$0.16Beat by $0.05
Revenue estimate$821.0M
EPS estimate$0.11
“Our financial results in the third quarter reflect the impact of the successful Idaho Falls divestiture and sustained momentum in our core business, underscoring the value of our short-stay surgical platform. Additionally, the recently announced amended merger agreement with HealthSpan Partners serves as further validation of our unique offering, while representing a compelling outcome for our patients, physicians, stockholders, and other stakeholders. We are excited to move forward with this next chapter as we continue to deliver high-quality care to all our patients and support our physicians, colleagues and health system partners.”
Next report
Date not yet announcedValuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Surgery Partners, Inc. report Q3 2026 earnings?
- Surgery Partners, Inc. (SGRY) reported Q3 2026 earnings on November 9, 2026 after market close.
- What were Surgery Partners, Inc.'s Q3 2026 revenue and EPS?
- Surgery Partners, Inc. reported revenue of $815.3M and eps of $0.16 for Q3 2026.
- Did Surgery Partners, Inc. beat estimates in Q3 2026?
- Revenue missed the consensus estimate of $821.0M by $5.7M. EPS beat the consensus estimate of $0.11 by $0.05.
- How did Surgery Partners, Inc.'s Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.8% from $821.5M a year earlier and eps grew 23.1% from $0.13.
- Where can I find Surgery Partners, Inc.'s Q3 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-124236) and the 10-Q periodic report (0001638833-26-000090) directly on SEC EDGAR. The filing index links above go to sec.gov.
